» Articles » PMID: 36674938

1,2-Dibenzoylhydrazine As a Multi-Inhibitor Compound: A Morphological and Docking Study

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jan 21
PMID 36674938
Authors
Affiliations
Soon will be listed here.
Abstract

In the framework of the multitarget inhibitor study, we report an in silico analysis of 1,2-dibenzoylhydrazine (DBH) with respect to three essential receptors such as the ecdysone receptor (EcR), urease, and HIV-integrase. Starting from a crystallographic structural study of accidentally harvested crystals of this compound, we performed docking studies to evaluate the inhibitory capacity of DBH toward three selected targets. A crystal morphology prediction was then performed. The results of our molecular modeling calculations indicate that DBH is an excellent candidate as a ligand to inhibit the activity of EcR receptors and urease. Docking studies also revealed the activity of DBH on the HIV integrase receptor, providing an excellent starting point for developing novel inhibitors using this molecule as a starting lead compound.

Citing Articles

Design, Synthesis, and Evaluation of Novel (-)-cis-N-Normetazocine Derivatives: In Vitro and Molecular Modeling Insights.

Costanzo G, Coco A, Cosentino G, Patamia V, Parenti C, Amata E Chem Biol Drug Des. 2024; 104(6):e70037.

PMID: 39726303 PMC: 11671793. DOI: 10.1111/cbdd.70037.


Investigating the effect of , on using integrated computational approaches.

Oluwafemi K, Jimoh R, Omoboyowa D, Olonisakin A, Adeforiti A, Iqbal N In Silico Pharmacol. 2024; 12(2):102.

PMID: 39524456 PMC: 11549268. DOI: 10.1007/s40203-024-00278-1.


Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2.

Fuochi V, Furnari S, Floresta G, Patamia V, Zagni C, Drago F Arch Pharm (Weinheim). 2024; 358(1):e2400545.

PMID: 39520338 PMC: 11704024. DOI: 10.1002/ardp.202400545.


Progress of the "Molecular Informatics" Section in 2022.

Rescifina A Int J Mol Sci. 2023; 24(11).

PMID: 37298393 PMC: 10253911. DOI: 10.3390/ijms24119442.


Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors.

Tomarchio R, Patamia V, Zagni C, Crocetti L, Cilibrizzi A, Floresta G Molecules. 2023; 28(6).

PMID: 36985701 PMC: 10058326. DOI: 10.3390/molecules28062731.

References
1.
Liu X, Zhang L, Tan J, Xu H . Design and synthesis of N-alkyl-N'-substituted 2,4-dioxo-3,4-dihydropyrimidin-1-diacylhydrazine derivatives as ecdysone receptor agonist. Bioorg Med Chem. 2013; 21(15):4687-97. DOI: 10.1016/j.bmc.2013.05.010. View

2.
Varrica M, Zagni C, Mineo P, Floresta G, Monciino G, Pistara V . DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma. Eur J Med Chem. 2017; 143:583-590. DOI: 10.1016/j.ejmech.2017.11.067. View

3.
Desideri I, Martinelli C, Ciuti S, Uccello Barretta G, Balzano F . Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy. Eur J Hosp Pharm. 2020; 29(5):259-263. PMC: 7677895. DOI: 10.1136/ejhpharm-2020-002389. View

4.
Seraj F, Kanwal , Khan K, Khan A, Ali M, Khalil R . Biology-oriented drug synthesis (BIODS), in vitro urease inhibitory activity, and in silico studies on ibuprofen derivatives. Mol Divers. 2020; 25(1):143-157. DOI: 10.1007/s11030-019-10032-x. View

5.
Kanwal , Khan M, Arshia , Khan K, Parveen S, Shaikh M . Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies. Bioorg Chem. 2018; 83:595-610. DOI: 10.1016/j.bioorg.2018.10.070. View